Dosage Forms

Susan Haigney is lead editor of Pharmaceutical Technology and Pharmaceutical Technology Europe.

Articles

Ralph G. Neas, president and CEO of the Generic Pharmaceutical Association, requests that Congress get involved in the support of a more competitive drug market.

GPhA Issues Statement on Generic Drug Costs

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Manufacturers face regulatory overhaul, while brand-generic debates escalate over biosimilars and labeling changes.

New Era for Generic Drugs

Sean Milmo is a freelance writer based in Essex, UK.

The European Union takes the lead in a global pilot project on the marketing approval of generic medicines, highlighting the challenges of achieving consensus among different nations.

WHO Promotes International Collaboration for Generic Drug Approvals

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

The total market for biopharmaceuticals in 2013 was $36.8 billion according to Kalorama Information. Meanwhile, Frost & Sullivan estimates that the biosimilars market, which it pegged at just $1.2 billion in 2013, will grow to $23 billion in 2019, or more than 20-fold increase.

Focus on Biosimilars

Regulatory agencies in Europe are working to harmonize the marketing approval pathway of generic medicines.

Harmonizing Marketing Approval of Generic Drugs in Europe

A GPhA report says generic drugs saved the US health system $239 billion in 2013.

Generic Pharmaceutical Association Reports Record Cost Savings

A surge in generic drug applications is testing FDA?s ability to reduce the backlog of ANDAs.

FDA Strategies Designed to Speed Generic Drug Approvals

Concerns about quality in overseas production may bring generic drug production back to the United States, concludes CPhI study.

Report Predicts Generics Production Return to US

The European system for assessing drugs will be used as a model internationally.

Europe Leads Generic-Drugs Assessment Project

FDA seeks high quality applications and products to facilitate approvals and reduce safety and supply problems.